Stay updated on MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial

Sign up to get notified when there's something new on the MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:25:34.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The webpage content has been updated to reflect a change in the study contact information. The previous contact details for Mirati Therapeutics have been replaced with new contact information for BMS Study Connect Contact Center for the clinical trial NCT05245500.
    Difference
    4%
    Check dated 2024-06-06T14:25:27.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying the need for a histologically confirmed diagnosis of a solid tumor malignancy with homozygous deletion of the MTAP gene, among other health conditions and prior treatments. This change provides more specific information on the requirements for study participants.
    Difference
    18%
    Check dated 2024-05-22T21:12:22.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:37:04.000Z thumbnail image

Stay in the know with updates to MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial page.